Disclosed is a pharmaceutical preparation for external application to the skin, which comprises a phosphorylated sugar. The phosphorylated sugar may be an inorganic salt of a phosphorylated sugar. The phosphorylated sugar may be in the form of a calcium salt, a magnesium salt, a potassium salt, a zinc salt, an ...

Provision of a stable α-lipoic acid. A method for 5 producing α-lipoic acid nanoparticles, the method comprising the steps of: preparing an aqueous dispersion liquid containing α-lipoic acid and a nonionic surfactant; adding a divalent metal salt into the aqueous dispersion liquid, wherein the divalent metal sa...

A composition for adsorbing or trapping unwanted matters, which composition comprises &agr;-1,4-glucan capable of functioning as an active ingredient. In particular, there is provided a composition capable of adsorbing or trapping unwanted matters through utilization of &agr;-l,4-glucan in form capable of functionin...

The purpose of the invention is to provide a glucan containing at least one residue selected from an N-acetylglucosamine residue and a galactose residue, and a modified product thereof. A branched glucan according to the invention is a branched glucan in which at least one residue selected from an N-acetylglucosamin...

The purpose of the present invention is to provide a glucosamine-containing glucan, a modified product of the glucosamine-containing glucan and a conjugate of the glucosamine-containing glucan. This glucosamine-containing glucan is a glucosamine-containing glucan wherein at least one glucosamine residue is bound, by...